Collectively , the evidence suggests that higher serum levels of 25(OH)D are associated with a reduced risk of asthma exacerbations , but there was little evidence to suggest an association with asthma incidence , prevalence or severity .
Asthma is a major public health issue .
The co-occurrence of the high prevalence of asthma and vitamin D deficiency documented globally in recent decades has prompted several investigations into a possible association between the two conditions .
The objective of this paper was to synthesize the evidence from studies that have measured the association between serum vitamin D  and asthma incidence , prevalence , severity and exacerbations .
Effect of Vitamin D Supplementation on Moderate to Severe Bronchial Asthma
Objective To define the therapeutic role of vitamin D in children with moderate to severe bronchial asthma as an adjunct to st and ard treatment . Methods Hundred asthmatic children of either sex , attending the respiratory and asthma clinic were enroled in the study . Diagnosis was made on the basis of history and clinical examination . R and omization was done using sealed opaque envelop method . In addition to the treatment as per GINA guidelines , one group received oral vitamin D3 ( Cholecalciferol ) 60,000 IU per month for 6 mo and the other group received placebo powder in the form of glucose sachet with a double blinded design . Monthly follow up of every patient was done and during every visit change in severity , level of control , Peak expiratory flow rate ( PEFR ) , steroid dosage , number of exacerbations and number of emergency visits were assessed . Results Monthly doses of 60,000 IU vitamin D significantly reduced the number of exacerbations as compared to placebo ( p = 0.011 ) . PEFR significantly increased in the treatment group ( p = 0.000 ) . Monthly doses of vitamin D significantly reduced the requirement of steroids ( p = 0.013 ) and emergency visits ( p = 0.015 ) . Control of asthma was achieved earlier in patients who received monthly vitamin D. Vitamin D significantly reduced the level of severity of asthma patients over 6 mo of treatment ( p = 0.016 ) . Conclusions Vitamin D has a definite role in the management of moderate to severe persistent bronchial asthma as an adjunct to st and ard treatment
Collectively , the evidence suggests that higher serum levels of 25(OH)D are associated with a reduced risk of asthma exacerbations , but there was little evidence to suggest an association with asthma incidence , prevalence or severity .
Asthma is a major public health issue .
The co-occurrence of the high prevalence of asthma and vitamin D deficiency documented globally in recent decades has prompted several investigations into a possible association between the two conditions .
The objective of this paper was to synthesize the evidence from studies that have measured the association between serum vitamin D  and asthma incidence , prevalence , severity and exacerbations .